New Delhi: Ind Swift Laboratories today reported narrowing of its net loss to Rs 12.37 crore for the third quarter ended on December 31, 2014. The company had a net loss of Rs 13.55 crore in the same period previous fiscal, Ind Swift Laboratories ... NDTV Profit, 1 month ago
Ind Swift Lab Q3 loss narrows to Rs 12 cr - Hindu Business Line, 1 month ago
Ind Swift Laboratories Q3 loss narrows to Rs 12.37 crore - Economic Times, 1 month ago
will hold a meeting of the Board of Directors of the Company on 6 February 2015, to consider the Unaudited Financial Results for the quarter ended 31 December 2014.Powered by Capital Market - Live NewsBusiness Standard, 2 months ago Ind-Swift Laboratories Ltd appoints Independent Director Equity Bulls, 2 months ago Ind-Swift Laboratories appoints director Capital Market, 2 months ago Ind-Swift Laboratories appoints Ashwani Vig as independent Director Money Control, 2 months ago
are Aurobindo Pharma, Cipla and Dr. Reddy's Laboratories 01/29 15:31 CST are Aurobindo Pharma, Cipla and Dr. Reddy's Laboratories DUBLIN, Jan. 29, 2015 DUBLIN, Jan. 29, 2015 /PRNewswire/ --Research and Markets ...Finwin, 1 month ago Market Research Reports, Inc. (www.marketresearchreports.com): Active Pharmaceutical Ingredients (API) Market in India 2015-2019, New Report Launched BusinessWeek, 2 months ago
The results which are expected today are Dena Bank, IDBI Bank, NMDC, Tata Steel, Tata Chemicals, Jet Airways, Finolex Industries, Gail (India), Gujarat Mineral Development Corporation, Apollo Tyres, Accel Frontline, Ansal Housing, Balrampur Chini ...India Infoline, 1 month ago
on your WebpageAdd Widget >Get your members hooked!